Form D · Pharmaceuticals
Remedy Pharmaceuticals, Inc.
New York, NY · CIK 0001501657
Offering snapshot reported Dec 4, 2015 · SEC filing
- Reported sold
- $9.06M Offering amount: $9.06M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 4, 2015 | Initial | $9,062,000 | No comparison | 30 | SEC filing |
| Feb 26, 2014 | Initial | $1,024,440 | No comparison | 4 | SEC filing |
| Jul 6, 2012 | Amendment | $4,083,809 | $1,379,587vs May 22, 2012 | 49 | SEC filing |
| May 22, 2012 | Initial | $2,704,222 | No comparison | 29 | SEC filing |
| Mar 6, 2012 | Amendment | $792,506 | $292,506vs Nov 22, 2011 | 3 | SEC filing |
| Nov 22, 2011 | Amendment | $500,000 | $250,000vs Oct 19, 2011 | 1 | SEC filing |
| Oct 19, 2011 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Sep 22, 2010 | Initial | $400,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-252449
Source: Form D, filed Dec 4, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Geliebter | Director |
| Sven Jacobson | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
122 West 27 Th Street 10 Th Floor
New York, NY, 10001
New York, NY, 10001